| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/18/1999 | WO1999007378A1 Nicotine antagonists for nicotine-responsive neuropsychiatric disorders |
| 02/18/1999 | WO1999007359A1 Use of cholinesterase inhibitors for treating attention deficit disorders |
| 02/18/1999 | WO1998040055A3 Anti-epileptogenic agents |
| 02/18/1999 | WO1998036764A3 Method of treating psychological and metabolic disorders using igf or igf/igfbp-3 |
| 02/18/1999 | DE19735410A1 New stable fumarate salt of pyrimidinol derivative dopamine D3 receptor ligand, having improved solubility and suitable for oral administration |
| 02/18/1999 | CA2301669A1 Peptides having potassium channel opener activity |
| 02/18/1999 | CA2300391A1 3-substituted 3,4,5,7-tetrahydro-pyrrolo[3',4':4,5]thieno[2,3-d]pyrimidine derivatives |
| 02/18/1999 | CA2300302A1 8-substituted-9h-1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives, as ampa/kainate receptor inhibitors |
| 02/18/1999 | CA2300142A1 1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives as ampa/kainate receptor inhibitors |
| 02/18/1999 | CA2299286A1 Bicyclic compounds as ligands for 5-ht1 receptors |
| 02/18/1999 | CA2298702A1 2-acylaminopropanamines as tachykinin receptor antagonists |
| 02/18/1999 | CA2297967A1 Purine inhibitor of protein kinases, g proteins and polymerases |
| 02/18/1999 | CA2297412A1 Anthranilic acid analogs |
| 02/18/1999 | CA2267066A1 Meningococcus vaccine comprising the valence of bz83 strain |
| 02/18/1999 | CA2245041A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists |
| 02/17/1999 | EP0897011A2 Novel arginine deiminase |
| 02/17/1999 | EP0897008A2 His5 |
| 02/17/1999 | EP0896822A1 4-Aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists |
| 02/17/1999 | EP0896578A1 NOVEL IMIDAZO 1,5-c]QUINAZOLINES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS |
| 02/17/1999 | EP0896540A1 Use of phosphonic acid esters for the treatment of functional disorders of the brain and depression |
| 02/17/1999 | EP0896539A1 Methods for treating emesis and central nervous system disorders using optically pure (+) norcisapride |
| 02/17/1999 | EP0516777B1 Brain resuscitation device |
| 02/17/1999 | CN1208418A Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use |
| 02/17/1999 | CN1208417A Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 02/17/1999 | CN1208412A Antagonists of gonadotropin releasing hormone |
| 02/17/1999 | CN1208402A Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
| 02/17/1999 | CN1208349A Composition for treating pain |
| 02/17/1999 | CN1208348A Method for treating pain |
| 02/17/1999 | CN1208345A Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof |
| 02/17/1999 | CN1208034A Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 02/17/1999 | CN1207921A Quick acting Chinese medicine for various headaches and its preparation |
| 02/17/1999 | CN1207896A Solid pharmaceutical dispersions with enhanced bioavailability |
| 02/17/1999 | CN1042133C N-substituted azabicycloheptane derivatives, the preparation and use thereof |
| 02/16/1999 | US5872226 Fibroblast growth factor homologous factor-1 (FHF-1) |
| 02/16/1999 | US5872146 Metalloproteinases involved in connective tissue breakdown, such as collagenase, stromelysin and gelatinase and tumor necrosis factor |
| 02/16/1999 | US5872145 Formulation of 5-HT agonist and NSAID for treatment of migraine |
| 02/16/1999 | US5872140 Vitamin D analogues |
| 02/16/1999 | US5872125 Polymorphs of lesopitron dihydrochloride and its hydrated forms, preparation processes and compositions containing it |
| 02/16/1999 | US5872119 2-Naphthamide derivatives and their therapeutic applications |
| 02/16/1999 | US5872118 Relaxation of skeletal muscle in spastic, hypertonic and hyperkinetic conditions |
| 02/16/1999 | US5872114 Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 02/16/1999 | US5872097 Oligopeptides with affinity to opioid receptors |
| 02/16/1999 | US5871996 First agent comprising isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg |
| 02/16/1999 | US5871745 Isolated virus having reverse transcriptase activity, second agent distinct from first, comprising nucleotides; both agents associated with multiple sclerosis and purifiable from viral isolate pol-2 and ms7pg |
| 02/16/1999 | CA2138020C Pharmaceutical composition containing botulinum b complex |
| 02/16/1999 | CA2066192C Radiation synovectomy compositions |
| 02/15/1999 | CA2224096A1 The g-protein coupled receptor hfia041 |
| 02/14/1999 | CA2239264A1 Novel uses |
| 02/12/1999 | CA2239835A1 Human sdr2 cdna clone |
| 02/12/1999 | CA2239819A1 Ftsz |
| 02/11/1999 | WO1999006572A1 Synaptojanin isoform |
| 02/11/1999 | WO1999006540A2 Inhibitors of cell-cycle progression and uses related thereto |
| 02/11/1999 | WO1999006436A1 Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006435A1 Dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006434A1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006433A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006432A1 Dipeptide and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006431A1 Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006423A1 83 human secreted proteins |
| 02/11/1999 | WO1999006410A1 Hydroxamic acid substituted fused heterocyclic metalloproteinase inhibitors |
| 02/11/1999 | WO1999006408A1 New 2,3-benzodiazepine derivatives |
| 02/11/1999 | WO1999006407A1 THERAPEUTICALLY ACTIVE 1,2,4-TRIAZOLO(4.,3-b) PYRIDAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS |
| 02/11/1999 | WO1999006406A1 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]-INDOLE-1-ACETAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY |
| 02/11/1999 | WO1999006397A2 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 02/11/1999 | WO1999006391A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof |
| 02/11/1999 | WO1999006390A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006384A1 1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring |
| 02/11/1999 | WO1999006383A1 Piperazine derivatives active on the lower urinary tract |
| 02/11/1999 | WO1999006381A1 A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent |
| 02/11/1999 | WO1999006375A1 Fused heterocyclic compounds and their use as kynurenine-3-hydroxylase inhibitors |
| 02/11/1999 | WO1999006374A1 Condensed pyrazole compounds |
| 02/11/1999 | WO1999006367A1 Caspases and apoptosis |
| 02/11/1999 | WO1999006354A1 Il-8 receptor antagonists |
| 02/11/1999 | WO1999006340A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 02/11/1999 | WO1999006066A2 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 02/11/1999 | WO1999006060A1 Methods for treating neurological deficits |
| 02/11/1999 | WO1999006057A1 Soya extract, process for its preparation and pharmaceutical composition |
| 02/11/1999 | WO1999006053A1 N6-substituted-adenosine-5'-uronamides as adenosine receptor modulators |
| 02/11/1999 | WO1999006045A1 Controlled release pharmaceutical compositions containing tiagabine |
| 02/11/1999 | WO1999006042A1 Caspases and apoptosis |
| 02/11/1999 | DE19734444A1 3-Substituierte 3,4,5,7-Tetrahydro-pyrrolo(3',4':4,5) thieno (2,3-d) pyrimidin-Derivate, ihre Herstellung und Verwendung 3-substituted 3,4,5,7-tetrahydro-pyrrolo (3 ', 4': 4,5) thieno (2,3-d) pyrimidine derivatives, their preparation and use |
| 02/11/1999 | DE19728737C1 Verfahren zur Erkennung und Bestimmung von GnRH-Rezeptoren und die Verwendung von GnRH-Agonisten und GnRH-Antagonisten zur Behandlung eines Tumors ausgehend vom Hirn und/oder Nervensystem und/oder den Hirnhäuten A method for the detection and determination of GnRH receptors and the use of GnRH agonists and GnRH-antagonists for the treatment of a tumor originating in the brain and / or nervous system and / or the meninges |
| 02/11/1999 | CA2298852A1 83 human secreted proteins |
| 02/11/1999 | CA2298668A1 Caspases and apoptosis |
| 02/11/1999 | CA2298617A1 Acyclic metalloprotease inhibitors |
| 02/11/1999 | CA2298573A1 Synaptojanin isoform |
| 02/11/1999 | CA2298506A1 Methods for treating neurological deficits |
| 02/11/1999 | CA2298115A1 Inhibitors of cell-cycle progression and uses related thereto |
| 02/11/1999 | CA2297988A1 Hydroxamic acid substituted fused heterocyclic metalloproteinase inhibitors |
| 02/11/1999 | CA2297894A1 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 02/11/1999 | CA2297757A1 Caspases and apoptosis |
| 02/11/1999 | CA2297096A1 Condensed heterocyclic compounds |
| 02/11/1999 | CA2297095A1 1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring |
| 02/11/1999 | CA2296606A1 Fused heterocyclic compounds and their use as kynurenine-3-hydroxylase inhibitors |
| 02/11/1999 | CA2296485A1 N6-substituted-adenosine-5'-uronamides as adenosine receptor modulators |
| 02/11/1999 | CA2296315A1 Therapeutically active 1,2,4-triazolo(4.,3-b) pyridazine derivatives as ligands for gaba receptors |
| 02/11/1999 | CA2294064A1 Il-8 receptor antagonists |
| 02/11/1999 | CA2291475A1 Dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2291473A1 Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2290750A1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |